Incidence and outcomes of endophthalmitis with in-house compounded intravitreal bevacizumab injections: A multicentric study.

Sagnik Sen Chitaranjan Mishra Naresh Babu KannanKim RamasamyGunasekaran RameshkumarPrajna Lalitha

Published in: Seminars in ophthalmology (2021)

In-house compounded injections of bevacizumab can reduce post-injection endophthalmitis to a minimum, with maintenance of proper asepsis and strict protocols by the compounding pharmacy.

Keyphrases

ultrasound guided
platelet rich plasma
metastatic colorectal cancer
risk factors
vascular endothelial growth factor
diabetic retinopathy
cataract surgery
metabolic syndrome
adipose tissue
optical coherence tomography